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LIMA side-branchAbstract Background: Coronary steal is an often encountered clinical condition attributable to
multiple etiologies. Diverse treatment modalities have been previously elucidated.
Aim: To elucidate the potential role of interventional approach using N-butyl Cyanoacrylate
(Histoacryl) to treat coronary steal.
Material and methods: We present four patients with coronary steal due to different causes. Three
patients had coronary arterial ﬁstulas, and the fourth patient underwent prior Coronary Artery
Bypass Graft (CABG) surgery with a patent unligated Left Internal Mammary Artery (LIMA)
side-branch. We report the attempted trans-catheter closure of the ﬁstulas and LIMA side-
branch using n-butyl cyanoacrylate as an embolic agent.
Results: In our series, Coronary angiography was the imaging modality used for diagnosing and
guiding the treatment of all cases. Multi-detector CT was used to track the pathway and termina-
tion of the ﬁstula in one case only. From the three ﬁstula cases, two originated from the left anterior
descending (LAD) coronary artery and one from the left circumﬂex (LCX) coronary artery. We
accomplished successful occlusion in two of the three ﬁstula cases and in the LIMA side-branch case
as well.
Conclusion: N-butyl Cyanoacrylate (Histoacryl) is a useful interventional embolic agent that
could be used to treat coronary steal of diverse etiology.
 2016 Egyptian Society of Cardiology. Production and hosting by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Coronary steal, sometimes called cardiac steal syndrome, is a
condition where an alteration in circulation patterns leads toreduction in the blood directed to a special zone of the coro-
nary circulation resulting in cardiac ischemia.1 Sometimes it
is intentionally used as the underlying mechanism in some
pharmacological cardiac diagnostic stress tests, induced by
dipyridamole or adenosine. However, coronary arterial
(coronary-cameral) ﬁstula, which is a connection between
one or more of the coronary arteries and a cardiac chamber
or a great vessel, is a rare defect which may induce coronary
Table 1 Patients’ presenting features and clinical characteristics.
Case Age Sex Symptoms Etiology of coronary steal Further investigations Associated conditions
1 52 M Dyspnea and
angina
Fistula from LCX to left PA – MDCT to conﬁrm
anatomy
– Stress ECG positive
for ischemia
Rheumatic mitral stenosis (MVA= 1.3 cm2)
2 58 M Angina Fistula from LAD to RA – –
3 48 F Exertional
angina
Fistula as Plexiform nidus from
LAD to PA
– –
4 72 M Angina Patent LIMA - side branch – Prior CABG, LIMA-LAD and non-grafted
LCX, Patent RCA
M: male, F: female, LAD: left anterior descending artery, LCX: left circumﬂex artery, RCA: right coronary artery, RA: right atrium, PA:
pulmonary artery, LIMA: left internal mammary artery, ECG: electrocardiogram, CABG: coronary artery bypass graft, MDCT: multi-detector
computed tomography, MVA: mitral valve area.
Table 2 Outcomes and follow-up.
Case Angiographic
outcome
Complications Clinical follow-up
1 Successful
occlusion
Trivial
hemoptysis
Improved symptoms and
negative stress ECG at
2 months. Few months
later underwent
successful PTMC.
Symptom-free and no
recurrence at 3 years
clinical and angiographic
follow-up
2 Successful
occlusion
None Improved symptoms at
1 year follow-up
3 Failed
occlusion
None Persistent symptoms.
Scheduled for covered
stent
4 Successful
occlusion
None Improved eﬀort tolerance
at 1 year follow-up
ECG: electrocardiogram, PTMC: percutaneous trans-venous mitral
commissurotomy.
262 T.A.N. Ahmed et al.steal.2,3 Usually these ﬁstulas terminate to the right side of the
heart, occasionally to the left, and either the right or the left
coronary arteries may be involved.4 On the other hand, after
Coronary Artery Bypass Graft (CABG) surgery, coronary
steal has been reported secondary to subclavian stenosis prox-
imal to the Left Internal Mammary Artery (LIMA). Alterna-
tively, though less commonly reported, a persistent unligated
side branch of the LIMA post-CABG could induce coronary
steal. Several percutaneous approaches for management of
coronary steal have been previously elucidated using detach-
able balloons, coils, stent grafts or Amplatzer occluder
devices.5–11 In this report we describe 4 different cases of symp-
tomatic patients with signiﬁcant ischemia due to coronary
steal, and the trans-catheter use of n-butyl cyanoacrylate
(NBCA) (Histoacryl, Melsungen, Germany) to treat such
cases. We also present a brief review of its properties and
use as an embolic agent.
2. Materials and methods
Three patients with coronary arterial ﬁstula (2 males, 1 female)
and one male patient with patent LIMA-side branch represent
our series of coronary steal cases. The patient presentingfeatures and clinical characteristics are listed in Table 1.
Informed consent was obtained from all patients prior to each
procedure. No institutional review board approval was
required for the performance of any of the procedures as the
use of n-butyl cyanoacrylate (NBCA) was considered an estab-
lished method of embolization in other vascular territories. All
cases were given a weight-adjusted intravenous bolus dose of
heparin at the onset of the procedure. Femoral approach
was used in all cases. A 6F extra back-up (XB 3.5) guiding
catheter was used to cannulate the LCA, in the three patients
with coronary ﬁstulas, and a guiding LIMA catheter was used
to cannulate the LIMA in patient with patent LIMA-side
branch. The process of NBCA preparation and injection has
been previously reported.12 After positioning the proper
guiding catheter in the ostium of the relevant artery, a
micro-catheter was placed co-axially through it and used to
selectively catheterize the main branch involved in the ﬁstula
or the side branch of the LIMA. In case of the ﬁstula, we were
able to advance the micro-catheter up to and even through the
ﬁstula itself. A Fine cross micro-catheter was used which was
manipulated over a 300 cm long soft-tip 0.014 in. guide-wire.
After appropriately placing the micro-catheter in position for
NBCA delivery, we prepared the NBCA mixture in a separate
set of stainless steel bowls, uncontaminated by saline or other
ﬂuids. In each case a mixture of 50% NBCA and 50% Lipi-
odol (Guerbet, Paris, France) was prepared and drawn up into
a 1 cc luer-lock syringe. The micro-catheter was ﬂushed with
5% Dextrose solution prior to injections of the NBCA mix-
ture, so as to avoid premature polymerization within the cathe-
ter. Contrast uncontaminated by saline was placed in a third
bowl to be used for check arteriograms prior to the glue injec-
tion. The 5% dextrose solution and clean contrast medium
were then drawn up into color-coded 5 ml luer-lock syringes.
The 5% dextrose solution and the NBCA containing syringe
were then sequentially attached to the hub of the
micro-catheter. The NBCA mixture was then injected under
real-time ﬂuoroscopic guidance creating a solid cast of glue
in the vessel or nidal lumen causing immediate occlusion. Once
a suitable glue cast had formed in the target vessel, slight neg-
ative pressure was applied by drawing back upon the plunger
of the 1 cc syringe, after which and upon verbal command of
the ﬁrst operator, the second operator rapidly but smoothly
removed the micro-catheter to avoid it becoming glued in-
situ. The micro-catheter was then discarded as it becomes
blocked by the NBCA and cannot be reused. Check angiogra-
Figure 1 (Case 1): (a) RAO view with cranial angulation, (b) lateral projection, and (c) RAO view with caudal angulation showing the
origin of the ﬁstula from a big LA branch arising from the proximal LCX. (d) RAO view with caudal angulation (best view) showing the
positioning of the guide wire and micro-catheter into the ﬁstula in preparation for cyanoacrylate injection. Post-injection angiographies in
the (e) RAO view with caudal angulation and (f) lateral projection showing successful complete occlusion of the ﬁstula.
Percutaneous treatment of coronary steal 263phy was then performed through the guiding catheter. Experi-
enced interventional cardiologists performed the initial coro-
nary catheterizations, whereas the NBCA mixtures were
prepared and injected by an experienced interventional radiol-
ogist in all cases. Secondary coil placement was kept as bail-
out plan in case unsatisfactory occlusion using NBCA was
encountered.3. Results
The outcomes and follow-up of all cases are listed in Table 2.
Regarding the ﬁstula cases, successful occlusion was accom-
plished in the ﬁrst 2 cases (Figs. 1 and 4), while in the third case
it was unsuccessful (Fig. 5). As for the fourth case (Fig. 6),
which was a patent LIMA-side branch, successful occlusion
was achieved using NBCA. In all accomplished cases, sec-
Figure 2 (Case 1): (a) Transverse CT chest with contrast, showing an abnormally dilated bronchial artery (BA) coursing toward LCX in
retro-cardiac region (arrow head). (b) A diagram elucidating more precisely the site of connection between the LCX and the bronchial
artery. The left panel shows the descending aorta giving the right bronchial artery (arrow head) and the right panel demonstrates a cross-
sectional diagram revealing the left atrial (LA) branch coming from LCX connected to the bronchial artery arising from the aorta in the
retro-cardiac space (Fig. 2b was adopted from Khalpey et al., Ann Thorac Surg 2009;88:303). Thus, the ﬁstula originates from a large left
atrial branch which arises from the proximal LCX and passes posteriorly over the LA, and then it communicates with the right BA. The
BA runs upward reaching to the lung hilum near tracheal bifurcation to anastomose with the left middle and lower lobe pulmonary
arteries.
264 T.A.N. Ahmed et al.ondary or bail-out coil placement was unnecessary since the
ﬁstulas or side branch was no longer seen after NBCA injec-
tion, thus achieving the desired goal. No complications were
encountered in the presented cases.
In case 1, for further conﬁrmation of the anatomical course
and termination of the ﬁstula, multi-detector CT (MDCT) was
performed. It revealed a large ﬁstula originating from the LCX
and passing posteriorly to anastomose with bronchial arteries
which in turn anastomose with the left middle and lower lobe
pulmonary artery (Fig. 2). Stress ECG turned out positive for
myocardial ischemia. After the NBCA injection setting, the
patient complained of mild chest pain with transient ECG
changes that relieved spontaneously. Cardiac enzymes levels
were not measured as these changes did not recur and the
patient remained asymptomatic after the procedure. On the
ﬁrst day, there was cough with scanty amount of blood inthe sputum. This did not recur and was managed conserva-
tively. Patient was discharged on 2nd day on optimum medical
treatment. Despite the presence of associated signiﬁcant mitral
stenosis, the patient’s symptoms and effort tolerance improved
considerably after ﬁstula closure. Scheduled follow-up after
2 months showed complete relieve of chest pain. Stress ECG
was negative for angina and ST depression, but dyspnea on
stage 3 was the cause of stopping test. Prior echocardiography
showed severe rheumatic mitral stenosis (MVA= 1.3 cm2,
Wilkin’s score 6/16), for which successful percutaneous
transvenous mitral commissurotomy (PTMC) was performed
a couple of months later. The patient remained asymptomatic
for 3 years, after which he started complaining again of exer-
tional chest pain. Coronary angiography was performed show-
ing the ﬁstula was persistently occluded, while there was a
newly developed signiﬁcant focal lesion in the mid-segment
Figure 3 (Case 1): Follow-up angiography 3-years after cyanoacrylate occlusion of the ﬁstula, (a) RAO view with caudal angulation and
(b) lateral projection showing persistently occluded ﬁstula, and a mid-segment signiﬁcant focal LAD stenosis (arrows) which was managed
by stenting with drug-eluting stent in another session (images not available).
Percutaneous treatment of coronary steal 265of LAD which was managed by PCI (Fig. 3). Case 2 was
uneventful, and went quite smooth with the NBCA injection.
Unlike the ﬁrst case, there was no hemoptysis, probably due
to the fact that the ﬁstula in the second case opens into the
RA and not directly into the PA. The patient was discharged
on the next day and he was doing well up to 1 year of
follow-up.
In case 3, there was difﬁculty in introducing the guide wire
selectively in the ﬁstula, which actually had a plexiform nidus
form, the origin of which from the LAD couldn’t be clearly
visualized. After several attempts from different angiographic
projections to access the ﬁstula with the guide wire and
micro-catheter, the procedure was declared unsuccessful.
Case 4 presents a different cause for coronary steal. This
patient had previous CABG surgery in the form of LIMA to
LAD and SVG to obtuse marginal (OM) branches of LCX.
Few years after the revascularization, the patient suffered from
recurrent angina which didn’t respond optimally to medical
treatment. His coronary angiogram showed patent right coro-
nary system and occluded left main coronary artery (LMCA).
The SVG to LCX was totally occluded from its origin, while
the LIMA to LAD was patent. However, a big side branch
from the LIMA was observed, which was not ligated at the
time of the surgery. This could limit adequate perfusion to
the LAD due to steal phenomenon. After heart team consulta-
tion, decision was initially to try opening the LMCA to revas-
cularize the LCX-OM territory, and if unsuccessful to tackle
the LIMA-side branch problem. Several attempts were made
to open the LMCA, with the aid of simultaneous dual injec-
tions from the RCA and LMCA (Fig. 6). Despite that, LMCA
couldn’t be opened. Decision was taken to proceed to LIMA-
side branch occlusion using NBCA as the embolic material.
The procedure was successful and the patient experienced left
sided chest pain with no ECG changes, which was resolved
with conventional analgesics. The patient had an uneventful
hospital course. Follow-up was available up to 1 year showing
improvement of symptoms.4. Discussion
In our case series, we present the use of n-butyl cyanoacrylate
(NBCA) in different etiologies of coronary steal: coronary
artery ﬁstula (2 patients), plexiform type of AV malformation
(1 patient) and patent unligated side branch of LIMA post-
CABG (1 patient). N-Butyl cyanoacrylate showed to be a use-
ful embolic agent that could be used for different causes of
coronary steal.
N-Butyl cyanoacrylate, available under the name His-
toacryl (B. Braun, Melsungen, Germany), has been so long
used as a liquid embolization agent in diverse neurovascular
and non-neurological endovascular indications.13–15 N-butyl
cyanoacrylate polymerizes immediately upon contacting ionic
medium as saline or blood. It is non-opaque angiographically
and to be rendered so it should be mixed with ethiodized oil
(Lipiodol). Furthermore, Lipiodol prolongs the polymeriza-
tion time. The relative ratio of NBCA to the diluent (lipiodol)
should be judged based on the rate of ﬂow through the ﬁstula.
The ﬂow rate in turn is determined by many factors such as
caliber, length and degree of tortuosity of the ﬁstula, as well
as the pressure difference between the artery of origin and
the destination vessel or chamber. This could be judged by
observing the contrast transit time from the artery to the des-
tination vessel or chamber. The concentration of NBCA in the
mixture should be matched to the velocity of ﬂow through the
ﬁstula. Higher ﬂow rates require higher concentrations of
NBCA which entails rapid polymerization. Nevertheless, using
different NBCA concentrations in different cases has no scien-
tiﬁc basis. In our case series we used a ﬁxed concentration of
50% NBCA in all cases. All our injections were performed
by the same interventional radiologist who had vast experience
with the use of NBCA in different non-cardiac settings and has
built up a cumulative experience to judge and control the injec-
tion rate according to the different determinants. Furthermore,
injections were made with the tip of the micro-catheter as close
as possible to the target site of obstruction, which was chosen
Figure 4 (Case 2): (a) LAO angiographic view with cranial angulation, (b) lateral view showing the ﬁstula (arrow) originating from the
LAD (arrow) and coursing to the PA. (c) and (d) same projections as above showing the injection of cyanoacrylate through the micro-
catheter which has been positioned deep into the ﬁstula. (e) and (f) same views showing successful occlusion of the ﬁstula.
266 T.A.N. Ahmed et al.carefully not to endanger the native coronary arteries and at
the same time not to cause embolization into the destination
vessel or chamber. This could still be unavoidable, as in our
ﬁrst case, where possible embolization to the right side of the
heart could have caused the slight hemoptysis encountered.
Other previous reports have also recorded this to inadvertently
happen.12 As shown in our cases, the tip of the micro-catheter
should be curved or placed at a bend in the target vessel so as
to immediately entrap the NBCA as it emerges from the micro-catheter tip and minimizes the chance of retrograde ﬂow. The
injection is continued until the target vessel is fully occluded,
which takes place immediately.
Our third case shows a different kind of ﬁstulous connec-
tion, which presents as a plexiform type of arteriovenous mal-
formation (AVM), in which multiple arterial feeders end in a
vascular conglomerate of multiple arteriovenous micro-
communications from which multiple venous drainers
emerge.16 Unlike high-ﬂow ﬁstulous type of AVM, low-ﬂow
Figure 5 (Case 3): (a) Right anterior oblique view of the LCA showing plexiform type coronary ﬁstula arising from proximal left
anterior descending (LAD) artery. (b) Same angiographic projection showing the wire with micro-catheter trying to access the origin of the
ﬁstula but it wouldn’t work.
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ﬁstula and therefore generally requires a lower concentration
mixture to achieve greater nidal penetration and ﬁlling. How-
ever, like in our case, accessing the small caliber arterial feeders
with the guide-wire and micro-catheter becomes so difﬁcult,
not to mention the higher risk of perforation or rupture, espe-
cially if the drainage was insufﬁcient with high nidal pressure.
Using polytetraﬂuoroethylene (PTFE)-covered stent grafts
may represent a better option for such cases to block the feed-
ing vessels and exclude the AVM.6,8,9 However, PTFE-covered
stents may pose unique challenges; discrepancy in the arterial
size of the native coronary artery may inadequately exclude
the ﬁstula. Furthermore, PTFE-covered stents carry the risk
of thrombosis or in-stent restenosis.17
A previous report has reported the use of NBCA for percu-
taneous closure of coronary artery ﬁstula.12 It showed success-
ful results, regardless of the reported complications. They
reported the use of different mixtures of NBCA ranging from
33 to 66%, depending on the ﬂow rate and anatomical criteria
of the ﬁstula. Despite that, they experienced some emboliza-
tion events into the destination vessels (PA in such case) with
resulting pulmonary infarction. We think what really matters
is to properly position the micro-catheter and to control the
injection rate so as to attain the best results and avoid both
harming the coronary arteries or embolization of NBCA to
the destination vessel or chamber. It is also important to con-
tinue with the injection until you get sure that the ﬁstula got
adequately occluded, otherwise you would require another
injection which carries further risk.
It is worth mentioning that NBCA is not an easy emboliza-
tion agent. It can be extremely difﬁcult to control in high ﬂow
ﬁstulas. Possible complications include accidental spilling of
NBCA into non-target vessels leading to ischemia and necrosis
of myocardial tissue. Also downstream vascular occlusions of
the destination vessels would lead to deleterious pulmonary or
systemic embolization.12 Inadvertent complications could be
avoided with the judicial selection of the appropriate candi-dates for the use of NBCA, as well as the proper technique
of injection by experienced operators.
Case 4 presents another unique kind of coronary steal
encountered in post-CABG patients, which happens due to
unligated side branches from the LIMA graft resulting in
ischemia due to ﬂow diversion from the distal grafted coronary
bed. Several previous studies reported the outcomes of percu-
taneous embolization of the LIMA side branches using detach-
able coil techniques,18–23 or Amplatzer vascular plug.24,25
Herein, we report the use of NBCA, at much lower expenses,
to successfully occlude a patent LIMA side branch. As a mat-
ter of fact, being end on arteries with no further communica-
tions justiﬁes a safer and applicable use of NBCA in such
conditions which are not uncommonly met in clinical practice
particularly with the evolution of minimally invasive CABG
surgery, where the surgeon may be unable to ligate the proxi-
mal side branches.
In our cases we planned the use of coils as secondary bail-
out embolization technique in case we had unsatisfactory
results with NBCA. However, the eventual results were satis-
fying and negated the need for additional coil embolization.
This provides evidence that in carefully selected cases with
proper injection techniques, NBCA embolization could hold
as a stand-alone technique in the management of different
causes of coronary steal. Alternatively, adjunctive ﬂow reduc-
tion techniques could be adopted. In a previous report about
the use of NBCA in occlusion of coronary ﬁstulas,12 adjunc-
tive coil embolization was used to create a sort of nest distal
to the NBCA injection site to act as a sort of ‘‘glue trap” pre-
venting inadvertent distal embolization of NBCA into the
destination vessel or chamber. Nevertheless, coil placement
could still carry high risk in high ﬂow situations, where
embolization beyond the ﬁstula site may inadvertently hap-
pen, especially when using inappropriate coil sizes. Not to
mention that the cost of a detachable coil system is much
higher than that of NBCA ampoule, especially if multiple
coils were to be used.
Figure 6 (Case 4): (a) Right anterior oblique (RAO) view with dual simultaneous injection into the LCA and RCA. (b) RAO view of the
LCA showing LM total occlusion. (c) Antero-posterior (AP) view of the LIMA showing a big patent side-branch with ﬂow divergence
from the LIMA. (d) Cyanoacrylate injection via micro-catheter into the LIMA side-branch. (e) Final result after CA injection showing
successful occlusion of the side-branch with patent ﬂow in the LIMA.
268 T.A.N. Ahmed et al.5. Conclusion
In our case series we showed that cyanoacrylate is a promising
embolic agent that could be used in treatment of coronary
steal. It has an affordable price compared to other embolic
agents and can be used in multiple clinical settings. However,proper case selections, as well as familiarity with the utilization
of NBCA are prerequisites for a safe and successful procedure.
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